Hernandez Hernandez R, Carvajal A R, Guerrero Pajuelo J, Armas de Hernandez M J, Armas Padilla M C, Barragan O, Boada Boada J J, Roa E
School of Medicine, Centro Occidental Lisandro Alvarado, Barquisimeto, Venezuela.
Am Heart J. 1991 Jan;121(1 Pt 2):389-94. doi: 10.1016/0002-8703(91)90877-k.
An in vitro assay was used to investigate the effects of doxazosin on the platelet aggregation induced by epinephrine, collagen, and adenosine diphosphate. Platelet-rich plasma from normotensive subjects and patients with hypertension was compared. Doxazosin produced a concentration-dependent inhibition of platelet aggregation in both groups, but significantly lower concentrations were required to inhibit platelet aggregation in plasma taken from patients with hypertension. The concentrations of doxazosin that inhibited platelet aggregation in vitro were similar to those that are used clinically to control blood pressure in patients with hypertension.
采用体外试验研究多沙唑嗪对肾上腺素、胶原蛋白和二磷酸腺苷诱导的血小板聚集的影响。比较了血压正常受试者和高血压患者的富血小板血浆。多沙唑嗪在两组中均产生浓度依赖性的血小板聚集抑制作用,但抑制高血压患者血浆中血小板聚集所需的浓度显著更低。体外抑制血小板聚集的多沙唑嗪浓度与临床上用于控制高血压患者血压的浓度相似。